FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula
, where radicals are described in the claims, as well as to salts and hydrates of said compound or salts thereof. The invention also relates to pharmaceutical compositions and medicinal agents for treating diseases associated with thrombosis.
EFFECT: highly effective treatment.
35 cl, 1 tbl, 488 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DEUTERATED BENZYL BENZENE DERIVATES AND METHODS FOR USE | 2009 |
|
RU2509773C2 |
| 1,3-DIARYL-SUBSTITUTED UREAS AS KINASE ACTIVITY MODULATORS | 2006 |
|
RU2402544C2 |
| TRIAZOLOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677698C1 |
| DERIVATIVES OF AZETHIDINE AS ANTAGONISTS OF CCR-3 RECEPTOR | 2003 |
|
RU2314292C2 |
| IMIDAZOTHIAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2683940C1 |
| DERIVATIVES OF 4-ANILINO-BENZODIAZINE, METHOD OF OBTAINING THEM (VERSIONS) PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITING THEIR PROLIFERATIVE ACTION AND METHOD OF TREATING CANCER IN WARM-BLOODED ANIMAL | 2003 |
|
RU2345989C2 |
| IMIDAZOPYRIMIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2691629C1 |
| METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION | 2004 |
|
RU2330682C2 |
| TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
| BENZOTRIAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677696C1 |
